Form 4: CoreWeave CDO Brannin McBee Reports Stock Sales
Insider Transaction Report
CoreWeave's Chief Development Officer, Brannin McBee, reported the conversion of 5,000 Class B shares to Class A common stock and subsequent sales of 5,500 Class A shares through pre-arranged trading plans.
Summary
- Brannin McBee, Chief Development Officer of CoreWeave, Inc., reported transactions involving Class A and Class B Common Stock.
- Transactions occurred on February 17, 2026, and the Form 4 was filed on February 19, 2026.
- McBee converted a total of 5,000 shares of Class B Common Stock into Class A Common Stock across three trusts: Canis Major 2024 Irrevocable Trust LLC (3,000 shares), Canis Major 2025 Family Trust LLC (1,000 shares), and Canis Minor 2025 Family Trust LLC (1,000 shares).
- Subsequently, McBee sold a total of 5,500 shares of Class A Common Stock through various trusts: Canis Major 2024 Irrevocable Trust LLC (3,000 shares), Canis Major 2025 Family Trust LLC (1,000 shares), Canis Minor 2025 Family Trust LLC (1,000 shares), and Canis Major SM Trust (500 shares).
- The sales were executed under a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2025.
- The sales occurred at weighted average prices ranging from $89.30 to $94.65 per share.
- Following these transactions, the Canis Major 2024 Irrevocable Trust LLC, Canis Major 2025 Family Trust LLC, and Canis Minor 2025 Family Trust LLC beneficially own 0 shares each, while the Canis Major SM Trust beneficially owns 54,000 shares.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly cautious event. While insider sales can sometimes be a negative signal, the execution under a pre-arranged 10b5-1 plan mitigates concerns about trading on new, negative information, suggesting a planned liquidity event rather than a loss of confidence.
Positives
- Transactions were conducted under a Rule 10b5-1 trading plan, indicating pre-planned sales rather than a reaction to new, undisclosed negative information.
Negatives
- An insider, the Chief Development Officer, sold a notable number of shares (5,500 Class A shares) across multiple trusts, which could be perceived negatively by some investors.
Risks
- Potential for negative market perception due to insider sales, even if pre-planned under a 10b5-1 plan.
- The reporting person has the power to remove and replace the trustee of the Canis Major SM Trust, which could be viewed as a concentration of control over trust assets.
Future Outlook
The filing details pre-planned sales under a Rule 10b5-1 trading plan, indicating a structured approach to liquidity or diversification by the insider rather than a reaction to immediate company-specific news.
Management Comments
- The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2025.
Industry Context
StockSavvy.ai notes that insider sales, even under a 10b5-1 plan, are common for executives seeking to diversify their portfolios or manage personal finances. For a company like CoreWeave in the high-growth AI infrastructure sector, any insider activity is closely watched for signals regarding future prospects, though 10b5-1 plans generally mitigate immediate negative interpretations.
Comparison to Industry Standards
- Insider selling under a Rule 10b5-1 plan is a standard practice among executives at publicly traded companies, similar to those seen at technology giants like NVIDIA, AMD, or Microsoft, allowing them to sell shares systematically without being accused of trading on material non-public information.
- The volume of shares sold (5,500 Class A shares) represents a portion of the insider's total holdings, which is typical for diversification strategies rather than a complete divestment, aligning with common executive financial planning.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Trading Plan Adoption | The reporting person adopted a Rule 10b5-1 trading plan on September 2, 2025, to facilitate the systematic sale of equity securities. | 2025-09-02 | Enhances transparency and provides an affirmative defense against insider trading allegations for pre-planned transactions, aligning with best practices for corporate governance regarding insider trading. |
Related Party Transactions
- Sales and conversions of securities were conducted through various irrevocable trusts (Canis Major 2024 Irrevocable Trust LLC, Canis Major 2025 Family Trust LLC, Canis Minor 2025 Family Trust LLC, Canis Major SM Trust) for which the reporting person serves as manager or has influence.
Stakeholder Impact
- Shareholders may interpret the insider sales as a signal, though the 10b5-1 plan context suggests a pre-planned event for personal financial management rather than a direct reflection of new company-specific news.
Next Steps
- Further transactions may occur under the existing Rule 10b5-1 trading plan as per its terms.
Key Dates
| Date | Description |
|---|---|
| 2025-09-02 | Adoption date of the Rule 10b5-1 trading plan by the reporting person. |
| 2026-02-17 | Date of reported transactions (conversion and sale of securities). |
| 2026-02-19 | Date the Form 4 was filed with the SEC. |
Keywords
CoreWeave, CRWV, Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, Brannin McBee, Chief Development Officer, Class A Common Stock, Class B Common Stock, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.